Table 2.

Continence status as measured by Wexner score

Reference	No. of patients	Duration of follow‐up (months)	Wexner score*	Wexner score > 10 (major incontinence)
Turrado‐Rodriguez et al.31	80 TaTME	37·6(17·7)†	10(5)†	n.r.
Rubinkiewicz et al.32	25 TaTME	Baseline	0 (0–2)	n.r.
		6	11 (8–12)	n.r.
Hanke et al.38	31 TaTME	3	9	n.r.
	17	6	6	n.r.
	13	9	4	n.r.
	10	12	2	n.r.
	7	18	4	n.r.
	4	24	0	n.r.
Elmore et al.39	12 TaTME	Baseline	n.r.	n.r.
		6	3 (1–8)	n.r.
Pontallier et al.40	38 TaTME	> 12	9 (2–20)	16 (42)
	34 LapTME		10 (3–20)(P = 0·932)	14 (41) (P = 0·936)
Kneist et al.41	10 TaTME	Baseline	1 (0–7)	0 (0)
		3	9 (1–20)	4 (40)
		6	7 (0–15)	3 (30)
Tuech et al.42	52 TEAP	> 12	4 (3–12)	7 (13) > 7 points
De'Angelis et al.43	32 TaTME	3	9 (3–15)	10 (32)
	32 LapTME	3	10·5 (4–19) (P = 0·115)	16 (50)
Rouanet et al.9	30 TEAP	12	11	n.r.
Keller et al.44	61 TaTME	Baseline	n.r.	n.r.
		12	n.r.	n.r.
Leão et al.46	20 TaTME	1	10·3	n.r.
	20	3	7·9	n.r.
	20	6	4·6	n.r.
	8	12	2·8	n.r.

Values in parentheses are percentages unless indicated otherwise

^*values are median (range), except

^†mean(s.d.). TaTME, transanal total mesorectal excision; n.r., not reported; LapTME, laparoscopic total mesorectal excision; TEAP, transanal endoscopic proctectomy. P values are shown for TaTME versus LapTME.